Peptide Associates Announces New GLP-3/Triple G Injection Program Redefining Access to Metabolic Support
Sarasota, FL – May 6, 2026 – Peptide Associates today announced the official launch of its new GLP-3/Triple G Injection Program, a next-generation metabolic support initiative designed to expand access to structured peptide-based wellness solutions through a simplified and patient-centered model. The new program reflects a growing demand for more streamlined and accessible approaches to […] Continue Reading

